Thrombotic Microangiopathies
Also known as: Thrombotic Microangiopathy / Thrombotic microangiopathy (disorder) / Thrombotic microangiopathy NOS / Other thrombotic microangiopathy / Purpura, Thrombotic Thrombocytopenic / Moschcowitz syndrome / Thrombocytopenic purpura, thrombotic / Purpura thrombopenic thrombotic / Purpura thrombopaenic thrombotic / Thrombotic thrombocytopenic purpura / Thrombotic thrombocytopenic purpura (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB01257 | Eculizumab | A recombinant humanized monoclonal antibody used to reduce the risk of hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). |
DB11580 | Ravulizumab | A monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB01257 | Eculizumab | Complement C5 | target |
DB11580 | Ravulizumab | Complement C5 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB04932 | Defibrotide | 2 | Completed | 1 |
DB04932 | Defibrotide | 2 | Not Yet Recruiting | 1 |
DB01257 | Eculizumab | 2 | Completed | 1 |
DB05202 | Egaptivon pegol | 2 | Terminated | 1 |
DB16418 | Narsoplimab | 2 | Completed | 1 |
DB16418 | Narsoplimab | 2 | Recruiting | 1 |
DB06151 | Acetylcysteine | 3 | Completed | 1 |
DB01257 | Eculizumab | 3 | Not Yet Recruiting | 1 |
DB00441 | Gemcitabine | 3 | Not Yet Recruiting | 1 |
DB16418 | Narsoplimab | 3 | Unknown Status | 1 |
DB14991 | Nomacopan | 3 | Recruiting | 1 |
DB11580 | Ravulizumab | 3 | Active Not Recruiting | 1 |
DB11580 | Ravulizumab | 3 | Recruiting | 2 |
DB11580 | Ravulizumab | 3 | Terminated | 1 |
DB01257 | Eculizumab | Not Available | Completed | 1 |
DB16418 | Narsoplimab | Not Available | Available | 1 |